MedPath

Risk Factors Associated With Binge Drinking Behaviors Among College Students

Not Applicable
Completed
Conditions
Binge Drinking
Registration Number
NCT02794311
Lead Sponsor
CHU de Reims
Brief Summary

The purpose of this study is to specify the psychological, cognitive, neuro-functional and genetic profile associated with binge drinker behaviors among young adults. Results will help identifying more precisely vulnerability factors associated with this pattern of alcohol consumption and guiding prevention efforts.

Detailed Description

Binge drinking behavior is characterised by speed of drinking on a particular occasion, frequency of drunkenness during the most recent six month period, and the percentage of times getting drunk when drinking. The prevalence of weekly binge drinking among European Union drinkers in 2009 was reported to be 28% of the student population, and 33% among all young people aged 15-24. The consequences of this behavior are multiple and often dramatic, they include: academic failure, violent acts, rape, domestic or road accidents. The study aims to identify vulnerability factors associated with binge drinking. The protocol explores the psychological (personality), neuropsychological (executive functions, memory), genetic (snp polymorphisms) and neuro-anatomical (fMRI) patterns associated with binge drinking behavior.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
125
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Neuropsychological test : Mini International Neuropsychiatric Interview (M.I.N.I)day 1
Neuropsychological test : Wisconsin Card Sorting Test (WCST)V2(3 weeks later)
Genetics tests (Single Nucleotide Polymorphism)V2(3 weeks later)
MRI - signal BOLD (" Blood Oxygen Level Dependant ").V3(up to 2 month)
Neuropsychological test : Family Informant Schedule and Criteria (FISC)day 1
Neuropsychological test : Alcohol Use Questionnaireday 1
Neuropsychological test :Trail Making Test, partie A et BV3(up to 2 month)
Neuropsychological test : Plus/Minus TestV3(up to 2 month)
Neuropsychological test :Go/No-GoV3(up to 2 month)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Reims

🇫🇷

Reims, France

© Copyright 2025. All Rights Reserved by MedPath